Healthcare shares fall as cash concerns overshadow clinical progress

• Starpharma fell 🔴 38.00% despite moving its lead radiopharmaceutical closer to human testing.
• Hydration Pharmaceuticals dropped 🔴 33.33% while seeking A$1.43 million for working capital.
• Saluda fell 🔴 26.76% after warning that it may need more capital within 12 months.
• Recce rose 🟢 15.52% as investors awaited an independent review of its Phase 3 wound-treatment data.